That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...

Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...

Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.

A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...

At the HIV Analyst & Investor Event on Tuesday, Gilead Sciences Inc. (NASDAQ:GILD) revealed that it is developing a ...

FOX 5 spoke exclusively with a participant in a study for a new injectable drug to prevent HIV. Emory University medical ...

Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates, mostly in ...

Experts are interested in finding the best strategies for HIV prevention, including the best options for pre-exposure prophylaxis. One study revealed that injection of the medication lenacapavir ...